Whitehawk Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
WHWK Nasdaq 2830 ir.whitehawktx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - Dec 1st, 2025 6:00 am
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Nov 26th, 2025 6:00 am
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London - Nov 11th, 2025 6:00 am
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - Nov 6th, 2025 6:00 am
Hedge funds investors own a significant stake of 37% in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) - Nov 1st, 2025 6:37 am
Tempus AI-Whitehawk Therapeutics Data Partnership Could Be a Game Changer for Tempus AI (TEM) - Oct 28th, 2025 9:09 am
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC - Oct 24th, 2025 10:30 am
Tempus AI Fuels Growth Through Strategic Biotech Collaborations - Oct 17th, 2025 7:45 am
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research - Oct 16th, 2025 6:30 am
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - Sep 2nd, 2025 6:00 am
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Aug 12th, 2025 3:32 am
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - Aug 7th, 2025 6:00 am
Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - Jul 22nd, 2025 6:00 am
Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series - Jun 19th, 2025 6:00 am
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference - May 28th, 2025 6:00 am
Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit - May 21st, 2025 6:00 am
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights - May 8th, 2025 2:05 pm
Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals - Mar 26th, 2025 6:00 am